AMRX 毛利润历史(2016–2025)
AMNEAL PHARMACEUTICALS, INC. (AMRX) 年度毛利润历史(来自 SEC 财报)—— 每个财年的申报值。
$1.1BFY2025 · FY2016 以来:$597.5M → $1.1B
| 财年 | 数值 | 同比 |
|---|---|---|
| FY2025 | $1.1B | +9.1% |
| FY2024 | $1.0B | +24.4% |
| FY2023 | $820.6M | +4.6% |
| FY2022 | $784.7M | +2.0% |
| FY2021 | $769.0M | +22.4% |
| FY2020 | $628.4M | +78.0% |
| FY2019 | $353.0M | -50.7% |
| FY2018 | $716.4M | +36.2% |
| FY2017 | $526.2M | -11.9% |
| FY2016 | $597.5M | — |
数据来自 SEC XBRL 申报 · 仅供参考 · 非投资建议